TrialOrphanet journal of rare diseases2026

An open-label single-arm phase 1/2a study to evaluate the safety and exploratory efficacy of a VM202 in patients with Charcot-Marie-Tooth disease 1A.

Hye Mi Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.